Find the right Medicare plan for 2025 — compare coverage and costs in minutes.

Compare Medicare Plans →
Medicare News MedCity News

Trust and AI Adoption in Medicine

The challenge isn’t whether AI can be used (it already is). It’s whether it can be trusted. And trust in medicine is not something healthcare professionals can afford to get wrong. The post Trust and AI Adoption in Medicine appeared first on MedCity News .

Read full article →
Medicare News MedCity News

Kailera’s Upsized IPO Brings In $625M for Pipeline of Injectable & Oral Obesity Drugs

Kailera Therapeutics’ IPO proceeds will support global clinical trials for its obesity drug candidates. Meanwhile, proteomics company Alamar Biosciences upsized its own IPO while clinical-stage biotechs Seaport Therapeutics and Hemab Therapeutics joined the IPO queue. The post Kailera’s Upsized IPO Brings In $625M for Pipeline of Injectable & Oral Obesity Drugs appeared first on MedCity News .

Read full article →
Medicare News MedCity News

FDA Nod for Merck HIV Drug Brings Competition to a Gilead Sciences Antiretroviral

Merck’s HIV drug Idvynso could become a drug choice for patients who need to switch from Gilead Sciences’ Biktarvy for safety or tolerability reasons. The Merck combination drug pairs two molecules that bring different mechanisms of action to suppressing HIV. The post FDA Nod for Merck HIV Drug Brings Competition to a Gilead Sciences Antiretroviral appeared first on MedCity News .

Read full article →
Medicare News MedCity News

Wearable Noise Is Exploding — Trust Is the Filter

The challenge is determining whether wearable data is reliable enough to relieve the review burden, guide care, support reimbursement, or reassure a patient who is worried about their heart rhythm at two o’clock in the morning. The post Wearable Noise Is Exploding — Trust Is the Filter appeared first on MedCity News .

Read full article →
Medicare News MedCity News

Neuro Startup Tortugas Unveils $106M and a Pipeline of Drugs for the Brain

Tortugas Neurosciences’ two lead programs are in-licensed oral small molecules in development for schizophrenia and tinnitus. The startup is led by veterans of Sage Therapeutics, a neuroscience biotech that was acquired last year. The post Neuro Startup Tortugas Unveils $106M and a Pipeline of Drugs for the Brain appeared first on MedCity News .

Read full article →
Medicare News MedCity News

The Next Era of Payment Integrity: Earlier Clinical Validation, True Transparency

By using AI-powered intelligence to shift clinical and coding validation earlier in the healthcare continuum, and unlocking upstream clinical data to inform downstream payment workflows, organizations can proactively prevent errors, reduce downstream churn and friction, and support more predictable, accurate, and timely payments. The post The Next Era of Payment Integrity: Earlier Clinical Validation, True Transparency appeared first on MedCity News .

Read full article →
Medicare News MedCity News

Revenue Isn’t the Signal: What Early-Stage Health Tech Investors Should Be Watching Instead

What matters just as much — if not more — is everything around that number: how customers adopt the product, how sales actually happen, and whether the company is building something that can scale inside a complex, regulated system. The post Revenue Isn’t the Signal: What Early-Stage Health Tech Investors Should Be Watching Instead appeared first on MedCity News .

Read full article →